Ghana Pharmaceuticals & Healthcare Q2 2018
Ghana’s pharmaceutical market will remain dominated by generic medicines as the country’s low per capita spend anduncertain regulatory environment play into the hands of local drugmakers over innovative multinational firms. In order to ensure thepopulation’s healthcare and access to safe medicines are not compromised by such measures, protectionist policies aimed atboosting local drugmaker capabilities must be accompanied by improvements to medical standards and regulations. While Ghanahas potential to boost it's attractiveness as an investment destination for international drugmakers in the West Africa region, it willremain a fundamentally challenging market in which to launch patented medicines.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook